Predictive value of white blood cell subtypes for long-term outcome following myocardial infarction

Atherosclerosis

Volumn 196, Issue 1, 2008, Pages 405-412

  Dragu, Robert ^a   Huri, Shafik ^a   Zuckerman, Robert ^a   Suleiman, Mahmoud ^a   Mutlak, Diab ^a   Agmon, Yoram ^a   Kapeliovich, Michael ^a   Beyar, Rafael ^a   Markiewicz, Walter ^a   Hammerman, Haim ^a   Aronson, Doron ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

C reactive protein; Heart failure; Inflammation; Leukocytes; Mortality; Myocardial infarction; Neutrophils

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; HUMAN; HYPERTENSION; INFLAMMATION; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL;

AGED; C-REACTIVE PROTEIN; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LEUKOCYTE COUNT; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEUTROPHILS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES;

EID: 38049000293     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.11.022     Document Type: Article

References (36)

1. Coller B.S. Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene?. Arterioscler Thromb Vasc Biol 25 (2005) 658-670
2. Thomson S.P., Gibbons R.J., Smars P.A., et al. Incremental value of the leukocyte differential and the rapid creatine kinase-MB isoenzyme for the early diagnosis of myocardial infarction. Ann Intern Med 122 (1995) 335-341
3. Nian M., Lee P., Khaper N., and Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 94 (2004) 1543-1553
4. Cannon C.P., McCabe C.H., Wilcox R.G., Bentley J.H., and Braunwald E. Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. OPUS-TIMI 16 Investigators. Am J Cardiol 87 636-639 (2001) A610
5. Barron H.V., Harr S.D., Radford M.J., Wang Y., and Krumholz H.M. The association between white blood cell count and acute myocardial infarction mortality in patients >or = 65 years of age: findings from the cooperative cardiovascular project. J Am Coll Cardiol 38 (2001) 1654-1661
6. Sabatine M.S., Morrow D.A., Cannon C.P., et al. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction 18 trial) substudy. J Am Coll Cardiol 40 (2002) 1761-1768
7. Patel M.R., Mahaffey K.W., Armstrong P.W., et al. Prognostic usefulness of white blood cell count and temperature in acute myocardial infarction (from the CARDINAL Trial). Am J Cardiol 95 (2005) 614-618
8. Maekawa Y., Anzai T., Yoshikawa T., et al. Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction: a possible role for left ventricular remodeling. J Am Coll Cardiol 39 (2002) 241-246
9. Suleiman M., Aronson D., Reisner S.A., et al. Admission C-reactive protein levels and 30-day mortality in patients with acute myocardial infarction. Am J Med 115 (2003) 695-701
10. Alpert J.S., Thygesen K., Antman E., and Bassand J.P. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36 (2000) 959-969
11. Lang R.M., Bierig M., Devereux R.B., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18 (2005) 1440-1463
12. Lewis E.F., Moye L.A., Rouleau J.L., et al. Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE study. J Am Coll Cardiol 42 (2003) 1446-1453
13. Yen M.H., Bhatt D.L., Chew D.P., et al. Association between admission white blood cell count and one-year mortality in patients with acute coronary syndromes. Am J Med 115 (2003) 318-321
14. Anzai T., Yoshikawa T., Shiraki H., et al. C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation 96 (1997) 778-784
15. James S.K., Armstrong P., Barnathan E., et al. Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy. J Am Coll Cardiol 41 (2003) 916-924
16. Suleiman M., Khatib R., Agmon Y., et al. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of C-reactive protein. J Am Coll Cardiol 47 (2006) 962-968
17. Morrow D.A., Rifai N., Antman E.M., et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 31 (1998) 1460-1465
18. Ferreiros E.R., Boissonnet C.P., Pizarro R., et al. Independent prognostic value of elevated C-reactive protein in unstable angina. Circulation 100 (1999) 1958-1963
19. Liuzzo G., Biasucci L.M., Gallimore J.R., et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 331 (1994) 417-424
20. Frangogiannis N.G., Smith C.W., and Entman M.L. The inflammatory response in myocardial infarction. Cardiovasc Res 53 (2002) 31-47
21. Vasilyev N., Williams T., Brennan M.L., et al. Myeloperoxidase-generated oxidants modulate left ventricular remodeling but not infarct size after myocardial infarction. Circulation 112 (2005) 2812-2820
22. Askari A.T., Brennan M.L., Zhou X., et al. Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction. J Exp Med 197 (2003) 615-624
23. Jordan J.E., Zhao Z.Q., and Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res 43 (1999) 860-878
24. Kilgore K.S., and Lucchesi B.R. Neutrophils and altered myocardial function. Am Heart J 139 (2000) 32-34
25. Harlan J.M., Killen P.D., Harker L.A., Striker G.E., and Wright D.G. Neutrophil-mediated endothelial injury in vitro mechanisms of cell detachment. J Clin Invest 68 (1981) 1394-1403
26. Hansen P.R. Role of neutrophils in myocardial ischemia and reperfusion. Circulation 91 (1995) 1872-1885
27. Jaeschke H., and Smith C.W. Mechanisms of neutrophil-induced parenchymal cell injury. J Leukoc Biol 61 (1997) 647-653
28. Litt M.R., Jeremy R.W., Weisman H.F., Winkelstein J.A., and Becker L.C. Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 min of ischemia. Evidence for neutrophil-mediated reperfusion injury. Circulation 80 (1989) 1816-1827
29. Forman M.B., Pitarys II C.J., Vildibill H.D., et al. Pharmacologic perturbation of neutrophils by Fluosol results in a sustained reduction in infarct size in the canine model of reperfusion. J Am Coll Cardiol 19 (1992) 205-216
30. Jolly S.R., Kane W.J., Hook B.G., et al. Reduction of myocardial infarct size by neutrophil depletion: effect of duration of occlusion. Am Heart J 112 (1986) 682-690
31. Vitola J.V., Forman M.B., Holsinger J.P., Atkinson J.B., and Murray J.J. Reduction of myocardial infarct size in rabbits and inhibition of activation of rabbit and human neutrophils by lidocaine. Am Heart J 133 (1997) 315-322
32. Barron H.V., Cannon C.P., Murphy S.A., Braunwald E., and Gibson C.M. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy. Circulation 102 (2000) 2329-2334
33. Jugdutt B.I. Monocytosis and adverse left ventricular remodeling after reperfused myocardial infarction. J Am Coll Cardiol 39 (2002) 247-250
34. Kyne L., Hausdorff J.M., Knight E., et al. Neutrophilia and congestive heart failure after acute myocardial infarction. Am Heart J 139 (2000) 94-100
35. Danesh J., Collins R., Appleby P., and Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 279 (1998) 1477-1482
36. Horne B.D., Anderson J.L., John J.M., et al. Which white blood cell subtypes predict increased cardiovascular risk?. J Am Coll Cardiol 45 (2005) 1638-1643